InvestorsHub Logo
Followers 20
Posts 5392
Boards Moderated 0
Alias Born 01/04/2012

Re: PennyStockInvestor post# 8919

Saturday, 02/11/2012 6:43:18 PM

Saturday, February 11, 2012 6:43:18 PM

Post# of 26138
I believe the call will be pointless and the information will be released when BioSante Pharmaceuticals, Inc. Presents at Biotechnology Industry Organization's 14th Annual BIO CEO & Investor Conference, Feb-14-2012 10:30 AM. I believe they want to time it with the announcement of the Bio-t-gel. This way if approved(which may have already happened) I don't know if there is lag time between the formal approval and when the PDUFA makes their announcement. I had read that usually the company gets a letter of approval for their timely disclosure before the FDA makes the formal announcement(don't know if this is factual).

Ceregene (privately owned company) was once part of Cell Genesys which Biosante bought out in 2009 and by process of elimination the product that makes the most sense to purchase would be Ceregene's CRE 120 used to combat Parkinson Disease. It has completed Phase 2 trials and would be ready to go straight to phase III possibly with the support of the Michael J. Fox foundation.

Note: Simes sits on Ceregene's board of directors.

CRE 120 trial

Realize that this is just conjecture. The announcement of Bio-t-Gel approval followed by the phase 3 trial for Parkinson would give a big pop.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.